Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Schorry, EK"" wg kryterium: Autor


Wyświetlanie 1-20 z 20
Tytuł:
KMT2C/D COMPASS complex-associated diseases [K CD COM-ADs]: an emerging class of congenital regulopathies.
Autorzy:
Lavery WJ; Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center (CCHMC), 3333 Burnet Avenue, Cincinnati, OH, 45229-3026, USA.
Barski A; Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center (CCHMC), 3333 Burnet Avenue, Cincinnati, OH, 45229-3026, USA.; Division of Human Genetics, CCHMC, Cincinnati, OH, USA.
Wiley S; Division of Developmental and Behavioral Pediatrics, CCHMC, Cincinnati, OH, USA.
Schorry EK; Division of Human Genetics, CCHMC, Cincinnati, OH, USA.
Lindsley AW; Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center (CCHMC), 3333 Burnet Avenue, Cincinnati, OH, 45229-3026, USA. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2020 Jan 10; Vol. 12 (1), pp. 10. Date of Electronic Publication: 2020 Jan 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Abnormalities, Multiple/*genetics
Craniofacial Abnormalities/*genetics
DNA-Binding Proteins/*genetics
Face/*abnormalities
Heart Defects, Congenital/*genetics
Hematologic Diseases/*genetics
Intellectual Disability/*genetics
Neoplasm Proteins/*genetics
Rubinstein-Taybi Syndrome/*genetics
Vestibular Diseases/*genetics
Abnormalities, Multiple/diagnosis ; Chromosome Deletion ; Chromosomes, Human, Pair 9/genetics ; Craniofacial Abnormalities/diagnosis ; DNA-Binding Proteins/metabolism ; Female ; Heart Defects, Congenital/diagnosis ; Hematologic Diseases/diagnosis ; Humans ; Intellectual Disability/diagnosis ; Male ; Neoplasm Proteins/metabolism ; Phenotype ; Rubinstein-Taybi Syndrome/diagnosis ; Vestibular Diseases/diagnosis
SCR Disease Name:
Kabuki syndrome; Kleefstra Syndrome
Czasopismo naukowe
Tytuł:
Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1.
Autorzy:
Payne JM; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Hearps SJC; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Walsh KS; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC.
Paltin I; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Barton B; Kids Neuroscience Centre, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.; Children's Hospital Education Research Institute, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.; The University of Sydney Children's Hospital Westmead Clinical School, University of Sydney, Westmead, New South Wales, Australia.
Ullrich NJ; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Haebich KM; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Coghill D; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Gioia GA; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC.
Cantor A; Department of Preventative Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Cutter G; School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.
Tonsgard JH; Division of Neurology, The University of Chicago Medicine Comer Children's Hospital, Chicago, Illinois.
Viskochil D; Department of Genetics, University of Utah, Salt Lake City, Utah.
Rey-Casserly C; Center for Neuropsychology, Boston Children's Hospital, Boston, Massachusetts.
Schorry EK; Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Ackerson JD; Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama.
Klesse L; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Fisher MJ; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Gutmann DH; Department of Neurology, Washington University School of Medicine, St Louis, Missouri.
Rosser T; Department of Neurology, Children's Hospital of Los Angeles, Los Angeles, California.
Packer RJ; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC.
Korf B; Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama.
Acosta MT; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC.; National Institutes of Health, National Human Genome Research Institute, Bethesda, Maryland.
North KN; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Pokaż więcej
Corporate Authors:
NF Clinical Trials Consortium
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2019 Dec; Vol. 6 (12), pp. 2555-2565. Date of Electronic Publication: 2019 Dec 03.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Neurofibromatosis 1*/complications
Neurofibromatosis 1*/drug therapy
Reproducibility of Results*
Clinical Trials as Topic/*standards
Cognitive Dysfunction/*diagnosis
Outcome Assessment, Health Care/*standards
Adolescent ; Biomarkers ; Child ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/etiology ; Double-Blind Method ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Lovastatin/pharmacology ; Male
Czasopismo naukowe
Tytuł:
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
Autorzy:
Abrams AJ; 1] John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [2] Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [3] Department of Biology, University of Miami, Coral Gables, Florida, USA.
Hufnagel RB; Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Rebelo A; 1] John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [2] Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA.
Zanna C; 1] Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto delle Scienze Neurologiche di Bologna, Ospedale Bellaria, Bologna, Italy. [2] Neurology Unit, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
Patel N; Department of Biology, University of Miami, Coral Gables, Florida, USA.
Gonzalez MA; 1] John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [2] Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA.
Campeanu IJ; Department of Biology, University of Miami, Coral Gables, Florida, USA.
Griffin LB; 1] Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan, USA. [2] Medical Scientist Training Program, University of Michigan, Ann Arbor, Michigan, USA.
Groenewald S; Department of Biology, University of Miami, Coral Gables, Florida, USA.
Strickland AV; 1] John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [2] Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA.
Tao F; 1] John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [2] Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA.
Speziani F; 1] John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [2] Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA.
Abreu L; 1] John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [2] Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA.
Schüle R; 1] John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [2] Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [3] Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. [4] German Research Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Caporali L; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto delle Scienze Neurologiche di Bologna, Ospedale Bellaria, Bologna, Italy.
La Morgia C; 1] Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto delle Scienze Neurologiche di Bologna, Ospedale Bellaria, Bologna, Italy. [2] Neurology Unit, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
Maresca A; 1] Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto delle Scienze Neurologiche di Bologna, Ospedale Bellaria, Bologna, Italy. [2] Neurology Unit, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
Liguori R; 1] Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto delle Scienze Neurologiche di Bologna, Ospedale Bellaria, Bologna, Italy. [2] Neurology Unit, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
Lodi R; Policlinico S. Orsola-Malpighi Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
Ahmed ZM; Department of Otorhinolaryngology Head and Neck Surgery, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Sund KL; Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Wang X; Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Krueger LA; Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Peng Y; Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Prada CE; Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Prows CA; Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Schorry EK; Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Antonellis A; 1] Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan, USA. [2] Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Zimmerman HH; Department of Pediatrics, Division of Medical Genetics, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Abdul-Rahman OA; Department of Pediatrics, Division of Medical Genetics, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Yang Y; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Downes SM; 1] Nuffield Department of Clinical Neuroscience, University of Oxford, John Radcliffe Hospital, Oxford, UK. [2] Oxford Eye Hospital National Health Service (NHS) Trust, Oxford, UK.
Prince J; Department of Biology, University of Miami, Coral Gables, Florida, USA.
Fontanesi F; Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida, USA.
Barrientos A; 1] Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida, USA. [2] Department of Neurology, University of Miami, Miami, Florida, USA.
Németh AH; 1] Nuffield Department of Clinical Neuroscience, University of Oxford, John Radcliffe Hospital, Oxford, UK. [2] Department of Clinical Genetics, Oxford University Hospitals NHS Trust, Oxford, UK.
Carelli V; 1] Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto delle Scienze Neurologiche di Bologna, Ospedale Bellaria, Bologna, Italy. [2] Neurology Unit, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
Huang T; Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Zuchner S; 1] John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA. [2] Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, USA.
Dallman JE; Department of Biology, University of Miami, Coral Gables, Florida, USA.
Pokaż więcej
Źródło:
Nature genetics [Nat Genet] 2015 Aug; Vol. 47 (8), pp. 926-32. Date of Electronic Publication: 2015 Jul 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Mutation*
Genetic Predisposition to Disease/*genetics
Mitochondrial Proteins/*genetics
Optic Atrophy, Autosomal Dominant/*genetics
Phosphate Transport Proteins/*genetics
Animals ; Animals, Genetically Modified ; COS Cells ; Charcot-Marie-Tooth Disease/genetics ; Charcot-Marie-Tooth Disease/metabolism ; Chlorocebus aethiops ; Embryo, Nonmammalian/embryology ; Embryo, Nonmammalian/metabolism ; Embryo, Nonmammalian/ultrastructure ; Exome/genetics ; Female ; HEK293 Cells ; Humans ; Male ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Microscopy, Confocal ; Microscopy, Electron, Transmission ; Mitochondrial Membranes/metabolism ; Mitochondrial Proteins/metabolism ; Muscle Proteins/genetics ; Muscle Proteins/metabolism ; Optic Atrophy, Autosomal Dominant/metabolism ; Optic Atrophy, Autosomal Dominant/pathology ; Pedigree ; Phosphate Transport Proteins/metabolism ; Protein Binding ; RNA Interference ; Saccharomyces cerevisiae Proteins/genetics ; Saccharomyces cerevisiae Proteins/metabolism ; Sequence Analysis, DNA ; Zebrafish/embryology ; Zebrafish/metabolism
Czasopismo naukowe
    Wyświetlanie 1-20 z 20

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies